191096-51-2 Usage
Uses
Used in Pharmaceutical Industry:
2-(2-Hydroxyethyl)-6-nitro-2H-1,4-benzoxazin-3(4H)-one is used as a synthetic intermediate for the production of pharmaceuticals. Its unique structure and chemical properties make it valuable in the synthesis of various drug molecules, contributing to the development of new therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(2-Hydroxyethyl)-6-nitro-2H-1,4-benzoxazin-3(4H)-one serves as a synthetic intermediate for the development of agrochemicals. Its reactivity and structural features allow for the creation of compounds with potential applications in crop protection and pest control, enhancing agricultural productivity and sustainability.
Used in Organic Synthesis Processes:
2-(2-Hydroxyethyl)-6-nitro-2H-1,4-benzoxazin-3(4H)-one is utilized as a key intermediate in various organic synthesis processes. Its versatile nature and reactivity enable the production of a wide range of chemical compounds, including those with potential applications in materials science, specialty chemicals, and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 191096-51-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,0,9 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 191096-51:
(8*1)+(7*9)+(6*1)+(5*0)+(4*9)+(3*6)+(2*5)+(1*1)=142
142 % 10 = 2
So 191096-51-2 is a valid CAS Registry Number.
191096-51-2Relevant academic research and scientific papers
HETEROCYCLIDENE-N-(ARYL)ACETAMIDE DERIVATIVE
-
Page/Page column 99, (2009/12/23)
The blow-described formula (I): [Ch. 1] a compound represented by formula (I) : (wherein k, m, n, and p each represent 0 to 2; j and q represents 0 or 1; R1 represents a halogen atom, a hydrocarbon group, a heterocyclic group, an alkoxy group,
4-Piperidinecarboxamide modulators of vanilloid VR1 receptor
-
Page/Page column 70; 71, (2010/11/08)
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.
